Wnt and Notch signaling pathways selectively regulating hematopoiesis Kun ZhouLifang HuangHanying Sun Original Article 10 March 2010 Pages: 749 - 757
Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation Aurora HernándezAna VillegasEduardo Anguita Original Article 09 February 2010 Pages: 759 - 765
Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain Núria ArandaFernando E. ViteriVictoria Arija Original Article Open access 28 January 2010 Pages: 767 - 773
Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma Zorica CvetkovićVesna VučićMaria Glibetić Original Article 03 February 2010 Pages: 775 - 782
Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP Panagiotis SamarasHelen HeiderChristoph Renner Original Article 05 March 2010 Pages: 783 - 787
Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors Chanchal RanaSeema SharmaUttam Singh Original Article 23 February 2010 Pages: 789 - 794
Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells Deok-Hwan YangMi-Hyun KimJe-Jung Lee Original Article 18 March 2010 Pages: 795 - 801
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma A. PalumboF. DaviesP. Moreau Original Article 16 March 2010 Pages: 803 - 811
Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors Byung Woog KangJoon Ho MoonSang Kyun Sohn Original Article 23 February 2010 Pages: 813 - 820
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease Agostina SiniscalchiTeresa DentamaroTommaso Caravita Letter to the Editor 02 December 2009 Pages: 821 - 822
Monoclonal gammopathy of undetermined significance related pyoderma gangrenosum successfully treated with autologous peripheral blood stem cell transplantation Ching-Ming ChangWen-Lee HwangChieh-Lin Teng Letter to the Editor 15 December 2009 Pages: 823 - 824
Hematoma of the iliopsoas muscle due to thrombocytopenia resulting from the administration of a third-generation cephalosporin Makoto OnoderaYasuhisa FujinoShigeatsu Endo Letter to the Editor 10 December 2009 Pages: 825 - 826
Acquired Hb H disease associated with elevated Hb F level in patient affected by primary myelofibrosis Ciro Roberto RinaldiPaola RinaldiCarmine Rinaldi Letter to the Editor 19 December 2009 Pages: 827 - 828
Imatinib, cytokines and interstitial lung disease in a patient with primary myelofibrosis Bruno RobibaroAnna KropfmuellerHeinz Gisslinger Letter to the Editor 19 December 2009 Pages: 829 - 831
Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure Yunya LuoGuangsen ZhangChongwen Dai Letter to the Editor 02 December 2009 Pages: 833 - 834
Protein C (PROC) gene mutations in two Indian families with purpura fulminans Navin PaiShrimati ShettyKanjaksha Ghosh Letter to the Editor 14 January 2010 Pages: 835 - 836
Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia Athanasios ChristoforidisMarina EconomouMiranda Athanassiou-Metaxa Letter to the Editor 19 January 2010 Pages: 837 - 838
Pneumocystis jiroveci pneumonia detected by FDG-PET Tomonori NakazatoAi MiharaTsunayuki Kakimoto Letter to the Editor 12 January 2010 Pages: 839 - 840
